An integrative pediatric oncology program addressing parents' quality of life-related concerns.

Informal caregiver Integrative Oncology Integrative medicine Pain Palliative care Parents Pediatric oncology

Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 11 06 2024
revised: 19 08 2024
accepted: 23 08 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 1 9 2024
Statut: aheadofprint

Résumé

Parents of children with cancer face bio-psycho-social-spiritual concerns which can significantly reduce quality of life (QoL). We examined the impact of an integrative oncology (IO) intervention on QoL-related concerns among parents of children in a pediatric hematology-oncology department. The study was prospective, controlled, non-randomized and patient-preferenced. Parents of children recently (≤ 6 weeks) diagnosed with cancer were assessed using the Measure Yourself Concerns and Wellbeing (MYCaW), Edmonton Symptom Assessment Scale (ESAS) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). An IO consultation was provided, with training in daily relaxation-breathing and manual treatments, and guidance on herbal medicine. Parents in both groups were re-assessed after three weeks. Of 68 parents consenting to participate, 37 (54%) underwent the intervention with 31 serving as controls. Multivariate analysis found the IO intervention group to contain more Hebrew-speakers (OR=5.96, 95% CI=1.3-27.3, P=0.022); females (OR=5.23, 95% CI=1.1-24.8, P=0.038); and report pain (OR=1.2, 95% CI=1.0-1.4, p=0.045) and impaired appetite on ESAS (OR=1.23, 95% CI=1.01-1.48, p=0.034) when compared to controls. Only the intervention group showed increased baseline-to-3-week scores for physical functioning (p<0.001), cognitive functioning (0=0.018) and fatigue on EORTC (p<0.001); and for ESAS appetite (p<0.001) and anxiety (p=0.02). ESAS sleep increased only in controls (p=0.029). IO interventions in pediatric hematology-oncology addressing QoL-related concerns among parents are feasible, potentially increasing predominantly physical symptoms and functioning. Further research is needed to confirm these "real-world" clinical outcomes, and the role of IO in "Caring for the Caregiver".

Identifiants

pubmed: 39218124
pii: S0885-3924(24)00992-8
doi: 10.1016/j.jpainsymman.2024.08.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Conflict of interests All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that they have received no support from any organization for the submitted work; have no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; and no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Orit Gressel (O)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel; Integrative Oncology Program, The Oncology Service, Lin, Zebulun, and Carmel Medical Centers, Clalit Health Services, Israel.

Ruth Ofir (R)

Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel.

Shifra Ash (S)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel.

Myriam Ben-Arush (M)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel.

Noah Samuels (N)

Center for Integrative Complementary Medicine, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.

Eran Ben-Arye (E)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Integrative Oncology Program, The Oncology Service, Lin, Zebulun, and Carmel Medical Centers, Clalit Health Services, Israel. Electronic address: eranben@netvision.net.il.

Classifications MeSH